Protein detail
FAD1
Bifunctional FAD diphosphatase/FAD synthase [Includes: FAD diphosphatase (EC 3.6.1.18) (EC 3.6.1.22) (FAD pyrophosphatase) (FADPPase) (FADHy) (NADH diphosphatase); FAD synthase (FADSy) (EC 2.7.7.2) (FMN adenylyltransferase) (FMNAT) (Flavin adenine dinucleotide synthase)]
Entry name FAD1 | UniProt ID | EVMP confidence score 0.50 |
Supporting publications (n) 7 | Transmembrane count | Protein classification Disease related genesEnzymesHuman disease related genesMetabolic proteinsPotential drug targetsPredicted intracellular proteins |
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40Basic Information11
Protein Names
Bifunctional FAD diphosphatase/FAD synthase [Includes: FAD diphosphatase (EC 3.6.1.18) (EC 3.6.1.22) (FAD pyrophosphatase) (FADPPase) (FADHy) (NADH diphosphatase); FAD synthase (FADSy) (EC 2.7.7.2) (FMN adenylyltransferase) (FMNAT) (Flavin adenine dinucleotide synthase)]
Protein Class (6)
Disease related genesEnzymesHuman disease related genesMetabolic proteinsPotential drug targetsPredicted intracellular proteins
Protein Function (6)
- Human disease related genes:Congenital disorders of metabolism:Congenital disorders of cofactor/vitamin metabolism
- Predicted intracellular proteins
- ENZYME proteins:Transferases
- Potential drug targets
- Enzymes
- Disease related genes
Ensembl
Entrez Gene Symbol
Gene Synonym (2)
FAD1PP591
Gene Description
Flavin adenine dinucleotide synthetase 1
Chromosome
1
Position
154983338-154993111
Supporting publications (n)
7
EVMP confidence score
0.50
Fluorescence & Localization5
Tissue SpecificbrainCell SpecificBasal prostatic cellsSingle-Nuclei Brain SpecificleukocyteBlood Cell SpecificgdT-cellBlood Lineage SpecificT-cells
Function & Pathway8
Protein Function (6)
- Human disease related genes:Congenital disorders of metabolism:Congenital disorders of cofactor/vitamin metabolism
- Predicted intracellular proteins
- ENZYME proteins:Transferases
- Potential drug targets
- Enzymes
- Disease related genes
Cellular Component (4)
Molecular Function (4)
Biological Process (3)
KEGG (3)
Reactome (3)
Canonical Pathways (3)
- M264 Pid toll endogenous pathway
- M5883 Naba secreted factors
- M5885 Naba matrisome associated
Mediation Categories
Metabolism mediation
Relations & Evidence9
Ligand-Receptor Signaling (4)
4 records.
| Category | Parent | Database | Transmitter | Receiver | Secreted | Plasma Membrane (Transmembrane) | Plasma Membrane (Peripheral) |
|---|---|---|---|---|---|---|---|
| intracellular | intracellular | ComPPI | No | No | No | No | No |
| intracellular | intracellular | GO_Intercell | No | No | No | No | No |
| intracellular | intracellular | UniProt_location | No | No | No | No | No |
| intracellular | intracellular | OmniPath | No | No | No | No | No |
Protein Complex Composition (4)
4 records.
| Component Name | Component Gene Symbols | Component UniProt ID | Stoichiometry | Database | Database IDs | References |
|---|---|---|---|---|---|---|
| FLAD1FUOMTAFA3 | A2VDF0Q7Z5A8Q8NFF5 | 0:0:0 | hu.MAP2 | |||
| FLAD1NUDT21RCC1 | O43809P18754Q8NFF5 | 1:1:1 | CompleatCFinder | Compleat:HC4937 | ||
| CSNK2BCYP3A4FLAD1FTH1HMGCS1JMJD6NDUFS1 | P02794P08684P28331P67870Q01581Q6NYC1Q8NFF5 | 1:1:1:1:1:1:1 | NetworkBlastCompleat | Compleat:HC4383 | ||
| FLAD1 | Q8NFF5 | 4 | PDB | PDB:8ron |
Sequence, Structure & Domains12
Sequences
Length
587
Mass
65,266
Sequence
MGWDLGTRLFQRQEQRSRLSRIWLEKTRVFLEGSTRTPALPHCLFWLLQVPSTQDPLFPGYGPQCPVDLAGPPCLRPLFGGLGGYWRALQRGREGRTMTSRASELSPGRSVTAGIIIVGDEILKGHTQDTNTFFLCRTLRSLGVQVCRVSVVPDEVATIAAEVTSFSNRFTHVLTAGGIGPTHDDVTFEAVAQAFGDELKPHPKLEAATKALGGEGWEKLSLVPSSARLHYGTDPCTGQPFRFPLVSVRNVYLFPGIPELLRRVLEGMKGLFQNPAVQFHSKELYVAADEASIAPILAEAQAHFGRRLGLGSYPDWGSNYYQVKLTLDSEEEGPLEECLAYLTARLPQGSLVPYMPNAVEQASEAVYKLAESGSSLGKKVAGALQTIETSLAQYSLTQLCVGFNGGKDCTALLHLFHAAVQRKLPDVPNPLQILYIRSISPFPELEQFLQDTIKRYNLQMLEAEGSMKQALGELQARHPQLEAVLMGTRRTDPYSCSLCPFSPTDPGWPAFMRINPLLDWTYRDIWDFLRQLFVPYCILYDRGYTSLGSRENTVRNPALKCLSPGGHPTYRPAYLLENEEEERNSRT
Alternative Products
Event=Alternative splicing; Named isoforms=5; Name=1; Synonyms=FADS1; IsoId=Q8NFF5-1; Sequence=Displayed; Name=2; Synonyms=FADS2; IsoId=Q8NFF5-2; Sequence=VSP_027947; Name=3; IsoId=Q8NFF5-3; Sequence=VSP_027947, VSP_027954; Name=4; IsoId=Q8NFF5-4; Sequence=VSP_027948, VSP_027949, VSP_027951, VSP_027952; Name=5; IsoId=Q8NFF5-5; Sequence=VSP_027948, VSP_027949, VSP_027950, VSP_027953
Alternative Sequence
1..97; Missing (in isoform 2 and isoform 3); 1..30; Missing (in isoform 4 and isoform 5); 31..124; LEGSTRTPALPHCLFWLLQVPSTQDPLFPGYGPQCPVDLAGPPCLRPLFGGLGGYWRALQRGREGRTMTSRASELSPGRSVTAGIIIVGDEILK -> MQPSSSTPPLHPYSTDGLIFPFNPQ (in isoform 4 and isoform 5); 374..437; SSLGKKVAGALQTIETSLAQYSLTQLCVGFNGGKDCTALLHLFHAAVQRKLPDVPNPLQILYIR -> NYLMFQTPSRSCISAASPLSLSWNSFYRTLSREQAIPENQIASPPSEAKGAEEPWMGPFPGQQG (in isoform 5); 374..393; SSLGKKVAGALQTIETSLAQ -> RDLMEEGHYAQSHWWHPRSQ (in isoform 4); 394..587; Missing (in isoform 4); 438..587; Missing (in isoform 5); 544..587; Missing (in isoform 3)
3D Structural Models
Turn
235..237; 358..361; 396..398; 516..519; 550..552
Helix
120..124; 131..141; 156..169; 187..194; 203..211; 218..221; 258..268; 269..272; 290..304; 333..345; 362..370; 375..393; 407..423; 443..456; 467..477; 493..496; 522..531; 538..541; 579..584
Beta Strand
112..118; 145..152; 171..177; 180..182; 199..201; 222..224; 228..230; 238..240; 245..248; 251..254; 280..288; 309..314; 322..332; 372..374; 399..402; 425..427; 432..437; 459..466; 483..485; 500..503; 506..508; 512..514
3D Structure
X-ray crystallography (2)
Domain & Motif Annotations
Region
110..354; FAD diphosphatase; 355..587; FAD synthase
Protein Families (2)
- MoaB/Mog family
- PAPS reductase family, FAD1 subfamily
Sequence Similarities
In the N-terminal section; belongs to the MoaB/Mog family.; SIMILARITY: In the C-terminal section; belongs to the PAPS reductase family. FAD1 subfamily.
Clinical Relevance5
Supporting Publications7
| PMID | Title | Abstract |
|---|---|---|
| 34265469 | Proteomic Landscape of Exosomes Reveals the Functional Contributions of CD151 in Triple-Negative Breast Cancer. | Furthermore, utilizing quantitative proteomics approach to reveal the proteomes of CD151-deleted exosomes and cells, we found that exosomal CD151 facilitated secretion of ribosomal proteins via exosomes while inhibiting exosome secretion of complement proteins. Moreover, we proved that CD151-deleted exosomes significantly decreased the migration and invasion of TNBC cells. Most importantly, we found that the tetraspanin CD151 expression levels in TNBC-derived serum exosomes were significantly higher than those exosomes from healthy subjects, and we validated our findings with samples from 16 additional donors. This is the first comparative study of the proteomes of TNBC patient-derived and CD151-deleted exosomes. |
| 36573687 | Proteomic and phosphoproteomic landscape of salivary extracellular vesicles to assess OSCC therapeutical outcomes. | No abstract available |
| 37403840 | Phosphoproteome analysis of cerebrospinal fluid extracellular vesicles in primary central nervous system lymphoma. | No abstract available |
| 38037300 | Proteomic profiling of paired human liver homogenate and tissue derived extracellular vesicles. | No abstract available |
| 38576002 | Therapy-induced senescent tumor cell-derived extracellular vesicles promote colorectal cancer progression through SERPINE1-mediated NF-κB p65 nuclear translocation. | No abstract available |
| 39996590 | Surface Double Dendritic Magnetic Microfibrils for Rapid Isolation and Proteomic Profiling of Extracellular Vesicles from Microliters of Biofluids. | No abstract available |
| 40689422 | Defining the Ovarian Cancer Precancerous Landscape through Modeling Fallopian Tube Epithelium Reprogramming Driven by Extracellular Vesicles. | No abstract available |